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Abstract 
DNA methylation is a well-studied genetic modification crucial to regulate the functioning of the genome. Its alterations play 
an important role in tumorigenesis and tumor-suppression. Thus, studying DNA methylation data may help biomarker 
discovery in cancer. Since public data on DNA methylation become abundant – and considering the high number of 
methylated sites (features) present in the genome – it is important to have a method for efficiently processing such large 
datasets. Relying on big data technologies, we propose BIGBIOCL an algorithm that can apply supervised classification 
methods to datasets with hundreds of thousands of features. It is designed for the extraction of alternative and equivalent 
classification models through iterative deletion of selected features.  
We run experiments on DNA methylation datasets extracted from The Cancer Genome Atlas, focusing on three tumor types: 
breast, kidney, and thyroid carcinomas. We perform classifications extracting several methylated sites and their associated 
genes with accurate performance (accuracy>97%). Results suggest that BIGBIOCL can perform hundreds of classification 
iterations on hundreds of thousands of features in few hours. Moreover, we compare the performance of our method with 
other state-of-the-art classifiers  and with a wide-spread DNA methylation analysis method based on network analysis. 
Finally, we are able to efficiently compute multiple alternative classification models and extract - from DNA-methylation 
large datasets - a set of candidate genes to be further investigated to determine their active role in cancer. BIGBIOCL, results 
of experiments, and a guide to carry on new experiments are freely available on GitHub at 
https://github.com/fcproj/BIGBIOCL. 
 
Keywords: classification; machine learning; DNA methylation; cancer; disease diagnostic predictive models; algorithms and techniques to 
speed up the analysis of big medical data. 
1 Introduction  
Tumor, or neoplasm, is a mass of tissue originated from an abnormal and 
uncontrolled division of eukaryotic cells. When tumoral cells invade and 
destroy surrounding tissues, the tumor is malignant and it is called 
cancer. According to the World Health Organization 
(http://www.who.int/mediacentre/factsheets/fs297/en/), nearly one six of 
death are caused by cancer. Since cancer is one of the leading causes of 
mortality, it is worth noting that research to fully understand its 
mechanisms and discover new ways to prevent and to treat this disease is 
fundamental to the human race. Transformation of healthy cells to 
tumoral ones is a complex process resulting from the interaction of 
genetic factors with external agents, like viruses, chemicals and physical 
mutagens. In this context, the importance of DNA methylation in 
carcinogenesis is widely recognized (Baylin, 2005; De Carvalho et al., 
2012; Feinberg et al., 2006; Figueroa et al., 2008; Zhuang et al., 2002). 
DNA Methylation is one of the most intensely studied genetic 
modification in mammals involving reversible covalent alterations of 
DNA nucleotides (Bird, 2002). In particular, the enzyme DNA 
methyltransferase catalyzes the conversion of the cytosine (typically in a 
CpG site) to 5-methylcytosine, by adding a methyl group (CH3) to 
cytosine residues in the sequence. In normal cells, this conversion results 
in different interaction properties assuring the proper regulation of gene 
expression and of gene silencing (Baylin et al., 2001). In the haploid 
human genome there around 28 million of CpG sites in methylated or 
unmethylated state (Stevens et al., 2013). It is well-known that 
inactivation of tumor-suppressor genes may occur as a consequence of 
hyper-methylation within the gene regions and a large range of cancer-
related genes can be silenced by DNA methylation in different types of 
tumors. Moreover, a global hypo-methylation, which induces genomic 
instability, also contributes to cell transformation (Kulis et al. 2010). 
Thus, methylation corresponds to inactivity, but inactivity of a repressive 
factor means stimulation. This means that studying DNA methylation 
data to identify drivers in cancer is challenging.  
Another challenge is given by the reduction of the cost of data generation 
that, especially after the employment of Next-Generation Sequencing 
technologies (Weitschek et al., 2014), has made available an enormous 
amount of raw data. The availability of big datasets creates problems 
with the application of classical algorithms for data mining and analysis 
(Greene et al., 2014).  
In this work, we focus on the adoption of big data technologies for the 
application of classification algorithms on large DNA methylation 
datasets. Even if there are many different definitions of big data, “Big 
data refers to datasets whose size is beyond the ability of typical database 
software tools to capture, store, manage and analyze” (McKinsey Global 
Institute, 2012). This definition does not focus on specific data size, but 
on the technology we adopt to manage those datasets.  
We want to extract a set of genes that may play a role in a specific 
tumor by applying supervised learning methods to DNA methylation 
datasets with a large number of features (450 thousand CpG positions). 
We aim to compute many classification models containing genes by 
applying optimized supervised learning algorithms, like Decision Trees 
(Quinlan, 1993) and Random Forests (Breiman, 2001; Svetnik et al., 
2003). We rely on Apache Spark MLlib (Meng et al., 2016), running in 
standalone or cluster mode, in order to cope with performance. In fact, 
the largeness of the input dataset does not allow to analyze and process it 
in an acceptable time with non-big data technologies.  
A previous classification study on DNA methylation (Danielsson et al., 
2015) proposed MethPed, a tool for the identification of pediatric 
tumors. Researchers built the classification model behind MethPed from 
DNA methylation datasets with 450 thousand of features. They firstly 
applied a large number of regression algorithms to select a subset of 
features with the highest predictive power; then, they adopted Random 
Forests to build the classification model. On the contrary, we want to 
apply classification algorithms to the entire dataset in order to obtain a 
large number of CpG sites and their associated genomic locations. 
Another study (Akalin et al., 2012) described methylKit, an R package 
for the analysis of DNA methylation data. This package adopts an 
unsupervised machine learning approach, working on unlabeled data. 
methylKit works in-memory and, even if it is multi-threaded, its 
execution is limited to a single machine. On our side, we want to 
perform supervised machine learning on a cluster of computational 
nodes, in order to be able to scale with the increasing dimension of input 
data. 
The algorithm proposed in our study is inspired by CAMUR for being 
applied to large input datasets. CAMUR (Classifier with alternative and 
multiple rule-based models) is a classification method that iteratively 
computes a rule-based classification model, eliminates from the input 
dataset combinations of extracted features, and repeats the classification 
until a stopping condition is verified (Cestarelli et al., 2016). The result 
of a CAMUR computation is a set of classification models. CAMUR 
worked on RNA sequencing cancer datasets with around 20 thousand 
features. In this work, we design and develop BIGBIOCL, a multiple 
tree-based classifier, to analyze DNA methylation datasets with more 
than 450 thousand features (Pidsley R. et al., 2013). Our goal is to 
extract candidate methylated sites and their related genes in few hours.  
2 Methods 
In our experiments on the application of big data technologies to the 
classification of large DNA methylation datasets, we consider three types 
of cancer: the Breast Invasive Carcinoma (BRCA), the Thyroid 
Carcinoma (THCA), and the Kidney Renal Papillary Cell Carcinoma 
(KIRP). We develop BIGBIOCL in order to run an iterative 
classification algorithm in big data environments, to achieve efficient 
supervised learning, and to extract multiple classification models. Then, 
we test our algorithm both in a single-machine and in a Hadoop YARN 
cluster.  
2.1 Datasets 
The Cancer Genome Atlas (TCGA) is a project started in 2005 and 
maintained by the National Cancer Institute and National Human 
Genome Research Institute (Weinstein et al., 2013).  The TCGA is a 2.5 
petabytes public dataset widely used in scientific research. Searching 
“The Cancer Genome Atlas” on PubMed reveals more than 2,500 
articles in the last 5 years. The TCGA dataset contains the genomic 
characterization of over 30 types of human cancer (Tomczak et al., 
2015) from more than 11,000 patients. The dataset includes cancer 
genome profiles obtained from several NGS methods applied to patient 
tissues, like RNA sequencing, Array-based DNA methylation 
sequencing, microRNA sequencing, and many others (Hayden 2014, 
Weitschek et al., 2014, Shendure, J. et. al 2008) .  
In our work, we focus on DNA methylation data. In particular, we 
consider profiles obtained using the Illumina Infinium Human DNA 
Methylation 450 platform (HumanMethylation450), which provides 
quantitative methylation measurement at CpG site level (Sandoval et al., 
2011). HumanMethylation450 allows assessing the methylation status of 
more than 450 thousand CpG sites (Dedeurwaerder et al., 2014), 
producing large datasets to be analyzed and interpreted. Even if 
HumanMethylation450 datasets can be useful for large-scale DNA 
methylation profiling, they raise problems of efficient data processing. 
 Consequently, we decide to explore the adoption of big data technologies 
and infrastructures to enable the possibility of efficiently applying 
machine learning algorithms to such large datasets. We rely on the latest 
TCGA data release available at The Genomic Data Commons data 
sharing platform (https://gdc.nci.nih.gov/). 
In our experiments, we use the beta value as an estimate of DNA 
methylation level. Beta value (Du P. et al., 2010) is defined as the ratio 
of the methylated allele intensity and the overall intensity (i.e. the sum of 
methylated and unmethylated allele intensities): 
βn =
max⁡(Methn,0)
max(Methn,0)+max(Unmethn,0)+⁡ε
 (1) 
where 𝑀𝑒𝑡ℎ𝑛 is the n
th methylated allele intensity, 𝑈𝑛𝑚𝑒𝑡ℎ𝑛⁡is the n
th 
unmethylated allele intensity, and⁡𝜀 is a constant offset used to regulate 
the beta value where both intensities are low. It is worth noting that beta 
value is a continue variable in the range [0, 1], where 0 means no 
methylation and 1 full methylation.  
Table 1. Datasets used in this study 
Dataset Number of Samples Number of Features 
BRCA 897 485,512 
THCA 571 485,512 
KIRP 321 485,512 
 
We focus on three DNA methylation datasets extracted from TCGA: 
BRCA, THCA, and KIRP (Table 1). For each dataset, we filter the input 
data matrix to cope with missing values and to exclude control cases 
(this is important to reduce the classification task to binary classification, 
having only tumoral and normal cases). The final data matrix (Table 2) 
has the following structure: 
 Rows represent samples, i.e. the profile of a patient tissue. The first 
row is the header, so it contains column names. 
 The first column contains ID of samples. The last column is the 
category, specifying if the sample is “tumoral” or “normal”. 
 All other columns represent CpG sites, and the corresponding cells 
contain the beta value for the CpG site. We use the Illumina 450k 
manifest to know where a CpG site is located and which gene 
corresponds to it. The manifest is available on Illumina website 
(https://support.illumina.com/array/array_kits/infinium_humanmet
hylation450_beadchip_kit/downloads.html). 
 Missing values are encoded with the question mark. 
Table 2. Structure of the DNA methylation data matrix extracted from 
TCGA 
Sample ID  cg13869341   …  cg00381604   Class 
TCGA-A7-A0DC-11 0.971644 … 0.017485 Tumoral 
TCGA-BH-A0BV-11A 0.925557 … ? Normal 
TCGA-BH-A0DZ-11A 0.907020 … 0.019204 Tumoral 
2.2 Supervised Learning 
The goal of our study is to develop an iterative algorithm that can 
efficiently extract a set of genes from large DNA methylation cancer 
datasets. The first step is the application of a supervised learning method 
(Tan et al., 2005; Weitschek et al., 2014). This is possible because the 
datasets used in this study (Table 1) are labeled datasets, i.e., we know if 
each tissue belongs to the ‘normal’ or ‘tumoral’ category. Using a 
labeled dataset (or a part of it) as a training set, the supervised learning 
algorithm infers some hypothesis from the features and builds a 
classification model, which is simply a function that assigns a category 
to a sample. We perform tests with both Decision Trees (Quinlan, 1993) 
and Random Forests (Breiman, 2001; Svetnik et al., 2003). Then, we 
extract CpG sites (features) from the classification model and the 
corresponding genes. The list of genes extracted from a classification 
model is part of the output of our algorithm. In fact, as we explain in the 
next section, our algorithm runs many iterations, and the overall result is 
the union of the results of each iteration. It is important to highlight that 
we are not interested in the decision model to classify new data (even if 
this would be possible), but to extract a list of candidate genes that may 
play a role in cancer.  
Decision Trees are used for recursive binary partitioning of the feature 
space. Starting from the root, which contains the entire training dataset, 
Decision Trees are built by splitting the dataset into distinct nodes, where 
a node defines the probability of a point to be of a certain category. The 
final prediction is the label of the final leaf node reached during the 
decision process. Decision Trees are smooth to understand and they 
allow validating the model with statistical tests (like entropy or 
information gain). Unfortunately, it is easy to create a tree that overfits 
the input data. In addition, since Decision Trees use a greedy algorithm, 
the optimal tree is sometimes not found. 
Random Forests solve many problems of Decision Trees, especially 
when applied to very large datasets. Random Forests run many Decision 
Trees in parallel and they fit well with big data technologies and map-
reduce algorithms, since data can be split on different machines. There 
are two points of randomness that reduce the possibility of overfitting 
and over generalization. First of all, each tree is created from a random 
selection of N data points from the training set. Then, during the decision 
process of a specific tree, there is a random selection of M features from 
the global set of features. For all those reasons, while both Decision 
Trees and Random Forests are explored, the final implementation of 
BIGBIOCL is based on Random Forests. 
2.3 BIGBIOCL: a multiple tree-based classifier for big 
biological data 
CAMUR (Cestarelli et al., 2016) is a supervised method that can extract 
alternative and equivalent classification models from a labeled dataset 
(Weitschek, 2016). CAMUR adopts an iterative feature elimination 
technique: it uses the supervised RIPPER algorithm (Cohen, 1995) to 
compute a rule-based classification model, iteratively eliminates 
combinations of features that appear in the model from the input dataset, 
and performs again the classification until a stopping condition is 
verified. Once a feature is eliminated from the dataset, it can be 
reinserted in the next iteration (loose execution mode) or discarded 
forever (strict execution mode). CAMUR has been successfully applied 
to RNA-sequencing data (Cestarelli et al., 2016) extracted from TCGA, 
and evaluated on Gene Expression Omnibus (GEO) datasets. Datasets 
used in CAMUR tasks contained at most 30 thousand of features and a 
thousand of samples. When trying to apply CAMUR to DNA 
methylation datasets, which contain hundreds of thousands of features, 
the algorithm suffers of memory and execution time problems.  
In this work we propose BIGBIOCL, a JAVA command-line software 
that is inspired by CAMUR to enable the efficient management and 
classification of large datasets. BIGBIOCL adopts big data solutions and 
introduces many innovations to CAMUR: 
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 BIGBIOCL is based on MLlib, the Apache Spark’s scalable 
machine learning library. The adoption of Apache Spark allows 
executing the algorithm on Hadoop YARN (Vavilapalli et al. 
2013) cluster, with the possibility to parallelize the machine 
learning task on several machines.  
 Even if both Decision Trees and Random Forests have been tested, 
the final implementation of BIGBIOCL is based on Random 
Forests. One of the reasons is that, Random Forests naturally fit 
with parallel computation, since each node of a cluster can 
compute a different tree of the forest and send the result back to a 
master node.  
 BIGBIOCL, following the CAMUR method, iteratively computes 
a Random Forest model. After each iteration, BIGBIOCL 
permanently removes all features that appear in the computed 
model from the input dataset, and not only combinations of them. 
This approach is similar to the CAMUR loose execution mode, but 
removing all extracted features makes the entire process lighter 
since there is no more the need to compute the power set at each 
iteration. Obviously, having hundreds of thousands of features 
guarantees that a relevant number of alternative classification 
models are still extracted, as we show in the next section.  
BIGBIOCL iterative procedure stops when the reliability of the 
classification model is below a given threshold, or when a maximum 
number of iterations has been reached. Both stopping conditions must be 
specified by the user as command-line parameters. We use the  
F-measure to evaluate the accuracy of classification models. The  
F-measure is defined as the weighted harmonic mean of precision (P) 
and recall (R). We decide to equally weight precision and recall, 
obtaining the formula: 
F − measure =
2PR
𝑃+𝑅
 (2) 
It is worth noting that F-measure is high when both precision and recall 
are high. Precision and recall are defined in terms of true positive TP (the 
number of samples that are assigned to a category and that belong to that 
category), false positives FP (the number of samples not belonging to a 
category but assigned to that category), and false negatives FN (the 
number of samples belonging to a category but not assigned to that 
category): 
P =
TP
𝑇𝑃+𝐹𝑃
⁡ ; ⁡R =
TP
𝑇𝑃+𝐹𝑁
⁡ (3) 
When the iterative algorithm stops, the software collects the list of 
features that appear in all computed classification models. Since features 
are CpG sites that are located in different genomic regions, we use a 
mapping file for discovering the gene where a CpG site is located (see 
section 2.1 for further details). The software can therefore derive a list of 
candidate genes as final output of the computation, associating them to 
the tumor under study. Extracted genes can then be explored and 
evaluated by biologists to investigate their role in cancer. Obviously, 
BIGBIOCL can be applied also to different datasets. In fact, it is not 
limited to DNA methylation data, but it works on any input dataset 
having the structure illustrated in Table 2.  
3 Results 
In this section, we discuss the path that led to the Random Forests 
implementation of BIGBIOCL, providing statistics about experiments 
and a discussion about results. All our experiments refer to the datasets 
listed in Table 1. 
First of all, we tried to use CAMUR in strict mode to extract 
candidate genes from the BRCA dataset. As we have previously noted, 
CAMUR works properly with TGCA RNA-sequencing data, where the 
number of features is around 30 thousand. The BRCA dataset - stored in 
a 6.5GB text file - includes more than 450 thousand of features and 
CAMUR cannot manage such amount of data. The experiment was 
executed using the workstation described in Table 3, allocating 22GB of 
RAM and 7 cores to the Java Virtual Machine (JVM). After 16 minutes, 
CAMUR ran out of memory. 
Table 3. Workstation used for experiments 
Parameter Value 
Architecture x86 
CPU Intel(R) Core(TM) i7-4790 CPU @ 3.60GHz 
Number of CPUs 8 
RAM 24GB 
OS CentOS Linux release 7.3.1611 
Java Version Oracle jdk1.8.0_131 
Afterwards, we executed several experiments, relying on Apache Spark 
MLlib: 
(1) Single iteration of Decision Trees. We ran Decision Trees in 
Spark local mode, in order to evaluate results and performance. 
(2) Single iteration of Random Forests. We ran Random Forests in 
Spark local mode, in order to compare results and performance 
with Decision Tree experiments. 
(3) Execution of Linear Support Vector Machines (SVMs) and 
Naïve Bayes. We ran SVMs and Naïve Bayes in Spark local 
mode to compare the accuracy of Random Forests results with 
other classification methods.  
(4) BIGBIOCL: this is the Random Forest iterative algorithm (with 
feature deletion) implemented with big data technologies. The 
algorithm was tested both in Spark local mode and on Apache 
Hadoop YARN multi-node cluster. 
Apache Spark local mode is a non-distributed single-JVM configuration 
that allows Spark to run all its execution components (i.e. driver, 
executor, scheduler, and master) in the same JVM. In local mode, the 
default parallelism is the number of threads specified as command line 
parameter. Table 4 and Table 5 show the configuration and results of 
experiments with a single iteration of Decision Trees in the same 
workstation used for testing CAMUR. In all our experiments we used 
70% of randomly sampled input data to build the model (training set), 
and 30% of data for the evaluation (test set). Results show that 
BIGBIOCL can manage large datasets with hundreds of thousands of 
features. 
Table 4. Configuration of Decision Tree experiments - Spark local 
mode (dataset: BRCA) 
ID  Memory Threads Max Depth Max Bins Impurity  
1 5 GB 4 5 16 Gini  
2 5 GB 4 5 32 Gini  
3 12 GB 7 5 32 Gini  
4 12 GB 7 10 32 Gini  
5 12 GB 7 5 8 Gini  
6 18 GB 7 5 128 Gini  
 
 Experiments with Decision Trees demonstrate that we were able to 
classify large datasets, even using only 5 GB of memory. The execution 
time decreases drastically if the parameter max bins is reduced. Even if 
execution time seems to be acceptable (the algorithm terminates at most 
in one hour), some observations led us to test (and then adopt) Random 
Forests:  
 We could extract only few features from each execution of the 
algorithm. We are interested in identifying a set of candidate genes 
for a specific type of cancer, thus having more features would be 
preferable. 
 Decision Trees offer few possibilities of parallelization. This is 
important especially in the context of multiple iterations, where 
parallelization can reduce the overall execution time. On the other 
hand, Random Forests allow splitting the data on many machines, 
reducing the execution time of each iteration. 
Table 5.  Results of Decision Tree experiments described in Table 4 
ID Build Time Evaluation time F-Measure #Features 
1 37.7 min 17.5 min 98,51% 2  
2 OOM - - -  
3 66.23 min 1.96 min 98.76% 4  
4 67.96 min 1.92 min 99.20% 4  
5 9.6 min 1.92 min 98.03% 3  
6 OOM - - -  
This is Table shows the execution time and results of a single iteration of Decision 
Trees. The configuration adopted for each experiment is provided in Table 4. “ID” 
is the unique identifier for an experiment. “Build Time” is the time needed to build 
the classification model, while “Evaluation time” is the time for the evaluation of 
the model on test data (30% of input data). The accuracy of the model is given by 
the F-measure. The column “#Features” represents the number of features that 
appear in the classification model, i.e. the CpG loci that can be extracted. “OOM” 
means that the experiment ran out of memory. 
Table 6 and Table 7 show results of some experiments with Random 
Forests. Overall, a single execution of Random Forests performs 
definitely better than a single execution of Decision Trees. Even if 
experiment 7 produced a result in more than one hour and a half, 
experiment 8 shows that increasing the memory from 5 GB to 12 GB 
dramatically improves the execution time. To build the model, 
experiment 8 required 38.5% of the time of the equivalent experiment 
with Decision Trees (ID=3). In addition, Random Forests produce more 
features, which is important to identify more genes that may play a role 
in cancer.  
Table 6. Configuration of Random Forest experiments - Spark local 
mode (dataset: BRCA) 
ID  Memory Threads Max Depth Max Bins #Trees Impurity  
7 5 GB 7 5 16 5 Gini  
8 12 GB 7 5 16 5 Gini  
9 12 GB 7 5 16 10 Gini  
Table 7.  Results of Random Forest experiments described in Table 6 
ID Build Time Evaluation time F-Measure #Features 
7 1 h 35 min 20.37 min 98,92% 33  
8 25.53 min 1.73 min 98.47% 40  
9 28.87 min 1.97 min 98.83% 77  
Additional experiments with other methods for large-scale 
classification tasks, i.e. Support Vector Machines (SVMs) and Naïve 
Bayes, justify the adoption of Random Forests in the final 
implementation of BIGBIOCL. Comparing Tables 7 and 9, we observe 
that experiments with SVMs show greater execution times than 
experiments with Random Forests. Even varying the amount of RAM 
(from 5GB to 18GB), execution time of SVMs does not change. In 
addition, while F-Measures of Tables 7 and 9 are comparable, SVMs do 
not provide a human interpretable model that we can use to create a list 
of candidate genes. We have also performed experiments with 
multinomial Naïve Bayes, but F-Measures were much lower and we 
could not rely on a human interpretable model to extract relevant 
features. 
Table 8. Configuration of SVM experiments - Spark local mode 
(dataset: BRCA) 
ID  Memory Threads 
Regularization  
method 
Regularization  
parameter 
#Iterations  
SVM1 12 GB 7 L2 1.0 100  
SVM2 12 GB 7 L2 1.0 200  
SVM3 12 GB 7 L1 0.1 100  
SVM4 12 GB 7 L1 0.1 200  
Table 9.  Results of SVM experiments described in Table 8 
ID Execution Time F-Measure  
SVM1 2 h 03 min 98.95%  
SVM2 3 h 32 min 98.74%  
SVM3 1 h 40 min 95.46%  
SVM4 1 h 19 min 99.16%  
 
For comparing the performance of our algorithm with a sequential 
implementation of Decision trees and Random Forest classifiers, we 
decided to run the classification analyses by adopting the Weka software 
package (Hall et al., 2009). The amount of memory we had to allocate 
was 24GB in order to permit the execution of the sequential algorithms.  
The running time of the sequential Random Forest on BRCA was 15.5 
minutes (model building and evaluation) setting the max bins to 2, the 
number of trees to 20, and the max depth to 5 obtaining an F-Measure 
value of 98.33%. Conversely, the Random Forest Apache Spark single 
node implementation with the same settings took 8 minutes with an  
F-Measure value of 99.81%. 
Moreover, when testing the sequential implementation of the Decision 
Tree results are even more noteworthy. A run of the sequential 
implementation with the same settings of experiment 5 in Table 4 did not 
compute a solution even after 20 days of computation, while the Apache 
Spark implementation terminated just in 10.5 minutes. Finally, it is 
worth noting that both Spark implementations need less memory (12GB 
and 18 GB) to perform the classification analyses. 
BIGBIOCL was tested both running Apache Spark in local mode and on 
Apache Hadoop YARN Cluster. Experiments with Hadoop Cluster were 
performed using PICO (http://www.hpc.cineca.it/hardware/pico), the 
latest Cineca’s Italian Supercomputing infrastructure for big data. PICO 
allows allocating computational nodes and memory on demand when 
running Hadoop jobs (Table 10). Experiments with Spark in local mode 
were conducted in the workstation described in Table 3. In both cases, 
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we used Apache Spark 2.1.1. BIGBIOCL implements the following 
iterative algorithm:  
 At each iteration, Apache MLlib Random Forests model is 
computed on the working dataset S. On a cluster, trees of the 
Random Forests can be computed in parallel on different nodes. 
 At iteration 0, S is equals to the input dataset. 
 After each iteration, the set of features F that appear in the 
computed model is removed from S. Thus, next iteration runs on 
the dataset⁡{S − F}. 
 Once eliminated, features are never reintegrated in the working 
dataset S. 
 The algorithm terminates when F-measure on test data is below a 
threshold MF (parameter provided by the user) or the number of 
iterations is bigger than a threshold MI (in the rest of this article 
we consider⁡𝑀𝐼 = 1000). 
Tables 11 and 12 show results of experiments running Spark in local 
mode. The input dataset is BRCA. As we can see, setting the F-measure 
threshold to 99%, BIGBIOCL ran 2 iterations in around one hour, 
extracting 224 candidate genes. Relaxing that constraint, we had more 
iterations and more candidate genes. When the F-measure threshold was 
set to 97%, BIGBIOCL executed 96 iterations, computing 5072 genes in 
less than 2 days. Experiments on Hadoop YARN Cluster are summarized 
in Tables 13 and 14. They were useful to evaluate how performance 
improves with parallelization on multiple computational nodes. Results 
are attractive. Experiment 16 (on Hadoop) corresponds to Experiment 12 
(Spark local mode) and its execution time was 22% of Experiment 12.  It 
is also interesting to note (Experiments 16 and 17) that increasing the 
number of working nodes of the cluster (so also the total number of 
CPUs) we got more iterations and more genes. 
We wish to highlight that all the extracted genes related to each tumor 
are available at supplementary data S1. Additionally, a comprehensive 
description of the experimentation is provided in the wiki of BIGBIOCL 
on GitHub. 
Furthermore, if we compare Experiment 18 (on Hadoop) with 
Experiment 13 (Spark local mode), we can notice again how the 
execution on a cluster outperforms the Spark local mode, both in terms 
of execution time and of number of features extracted. On average, 
running BIGBIOCL in Spark local mode requires around 1500 seconds 
to generate the classification model at each iteration, while using 3 
PICO’s nodes on Hadoop YARN cluster the average time to build a 
classification model is 330 seconds. 
Table 10. PICO’s hardware, used for experiments with Hadoop Cluster 
Parameter Value 
Total Nodes 66 
CPU Intel Xeon E5 2670 v2 @2.5Ghz 
Cores per node 20 
RAM per node 128 GB 
 
Tables 15 and 16 show results of some experiments with THCA and 
KIRP datasets. Experiments refer to the execution of BIGBIOCL in 
Spark local mode, using the workstation described in Table 3. On 
average, the time to build a classification model for the KIRP dataset is 
340 seconds, while for THCA this number increases to 945 seconds. 
This result is quite obvious, since THCA contains 571 samples, while 
KIRP only 321. What is interesting to note is that on THCA the 
algorithm stops after 7 iterations, while on KIRP after 34 iterations, even 
if the KIRP dataset contains less samples. This depends on the different 
distribution of beta values in the two datasets. 
For estimating the execution time of a sequential implementation of 
our algorithm, we can consider experiment number 17 (Tables 13 and 
14) whose execution time was 13 h 30 min. If we run the same number 
of iterations (i.e., 116) with the sequential implementation of Random 
Forest of the Weka software package, the execution time will be at least 
of 30 h (not taking into account potential overhead).  
Table 11. Configuration of BIGBIOCL experiments - Spark local mode 
(dataset: BRCA) 
ID  Memory Threads Max Depth Max Bins #Trees 
Stopping  
Condition 
 
10 18 GB 7 5 16 5 F-measure < 98% 
11 18 GB 7 5 16 10 F-measure < 98% 
12 18 GB 7 5 16 10 F-measure < 97% 
13 18 GB 7 5 16 20 F-measure < 99% 
Table 12.  Results of BIGBIOCL experiments described in Table 11 
ID Overall Time #Iterations #Features #Distinct Genes  
10 3 h 33 min 8 331 230  
11 13 h 16 min 26 2345 1460  
12 46 h 34 min 96 9780 5072  
13 1 h 2 min 2 329 224  
“Overall time” is the time to execute all iterations. For each iteration, execution 
time includes the time to build the model, the time to evaluate the model on test 
data, and the time to evaluate the model on training data. 
Table 13. Configuration of BIGBIOCL experiments - Hadoop YARN 
Cluster (dataset: BRCA) 
ID  #Nodes 
Mem 
per node 
CPU 
per node 
Max 
 depth 
Max  
bins 
#Trees 
Stopping  
Condition 
 
14 2 96 GB 20 5 16 5 F-measure < 98% 
15 2 96 GB 20 5 16 10 F-measure < 98% 
16 2 96 GB 20 5 16 10 F-measure < 97% 
17 3 96 GB 20 5 16 20 F-measure < 97% 
18 3 96 GB 20 5 16 20 F-measure < 99% 
“#Nodes” is the number of PICO’s nodes allocated to the execution of the 
experiment. For each working node, we specified an amount of memory (“Mem per 
node”) and the number of CPU (“CPU per node”).  
Table 14.  Results of BIGBIOCL experiments described in Table 13 
ID Overall Time #Iterations #Features #Distinct Genes  
14 28.58 min 4 165 123  
15 1 h 56 min 16 1352 907  
16 10 h 36 min 88 8722 4607  
17 13 h 30 min 116 24984 9539  
18 22.15 min 3 507 352  
 
 
 Table 15. Configuration of BIGBIOCL experiments - Spark local mode 
(datasets: THCA and KIRP) 
ID  Memory Threads 
Max 
 depth 
Max  
bins 
#Trees 
Stopping  
Condition 
 
THCA 19 18 GB 7 5 16 5 F-measure < 97% 
KIRP 20 18 GB 7 5 16 5 F-measure < 97% 
Table 16.  Results of BIGBIOCL experiments described in Table 15 
ID Overall Time #Iterations #Features #Distinct Genes  
THCA 19 2 h 13 min 7 541 398  
KIRP 20 4 h 21 min 34 1215 852  
 
In order to compare our results with a wide-spread DNA methylation 
analysis method, we followed the procedure described in (Bartlett, et al. 
2014). We have computed all the pairwise Pearson correlation 
coefficients (PPCC) between all CpG islands in the three examined 
datasets (BRCA, KIRP, and THCA). The aim of this operation was to 
construct a correlation network for each tumor differentiating normal and 
tumoral tissues.  
To achieve this goal, a cleaning of the dataset was required. In 
particular, for each tumor, we have replaced the unavailable 
measurements in our datasets with the mean value computed on the 
known beta values. Additionally, because of the nature of this analysis, 
we have fixed a threshold at 0.9 on the correlation measure to identify 
the strong correlated CpG islands only. This means that, if the 
correlation between the island X and the island Y is greater than 0.9 (in 
module), an edge between X and Y will be inferred. 
It is worth noting that this kind of analysis was extremely time 
consuming due to the dimension of our datasets and due to the non-
parallel implementation of the method described in (Bartlett, et al. 2014), 
as shown in Table 17.  
Due to the small dimension of the inferred networks (Figure 1, 2, 3), 
any analytical method from network theory is useful, except in the case 
of KIRP (tumoral tissue) in which a quasi-clique is emerged (see Figure 
2). For this reason, we have considered all the CpG islands in our 
networks as relevant features to compare with the novel feature 
extraction method proposed in this paper. 
We mapped the extracted CpG islands to the genes and we 
investigated if they are equal to the ones computed by BIGBIOCL. 
Indeed, when analyzing BRCA we found that seven out of eight genes 
appear also in the results of BIGBIOCL (AGRN, ISG15, SAMD11, 
SDF4, SPICE1, TNFRSF18, TNFRSF4). For KIRP two out of six genes 
appear also in BIGBIOCL (ZNF132, SAMD11), while for THCA no 
common genes have been identified. For further details the reader may 
refer to supplementary material S2. We wish to highlight that our method 
BIGBIOCL extracts many novel genes, which represent additional 
knowledge with respect to standard correlation analysis. 
 
 
 
Figure 1. Inferred correlation network for the BRCA tumor 
Figure 2. Inferred correlation network for the KIRP tumor 
 
Figure 3. Inferred correlation network for the THCA tumor 
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Table 17. Computational time and inferred nodes and edges with the 
DNA methylation network correlation analysis (Bartlett, et al. 2014) 
implemented in JAVA and executed on the Microsoft Azure Cloud 
Computing environment using a dual core virtual processor with 14 GB 
RAM memory and Ubuntu Linux 17.04 operating system 
Disease Tissue Experiments Time Nodes Inferred edges  
BRCA 
normal 97 3d 20h 20m 5 5  
tumoral 798 18d 12h 57m 49 34  
KIRP 
normal 44 1d 17h 30m 0 0 
 
tumoral 275 8d 7h 34m 37 73 
 
THCA 
normal 55 2d 3h 44m 2 1 
 
tumoral 514 11d 1h 4m 21 14  
 
4 Discussion 
Our experiments demonstrate that BIGBIOCL can compute multiple 
classification models for datasets with hundred thousands of features in 
few hours. In addition, thanks to the possibility to execute the software 
on a Hadoop cluster, execution time can be reduced even by 75% 
compared to Spark local mode. Obviously, the possibility of the software 
to reach a high level of parallelism allows adding computational nodes to 
the cluster when the size of the input dataset explodes. The first 
parameter that can be tuned to improve the parallelism and performance 
is the number of trees of the Random Forests. This number should be 
increased only when there is an increment in the size of the input dataset. 
Increasing the number of trees causes an increase of the training time, 
which can be contained by adding more computational nodes to the 
cluster (in fact, trees can be computed in parallel in different nodes).  
We compared BIGBIOCL with standard DNA methylation network 
analysis and other supervised machine learning methods (i.e., SVM and 
Naïve Bayes) obtaining new knowledge in terms of extracted CpG sites 
and related genes. In fact, BIGBIOCL represents a novel approach to 
DNA methylation data classification. BIGBIOCL performs classification 
using the entire set of features in the input dataset, even when features 
are hundreds of thousands. This is made possible by the adoption of big 
data technologies for the computation of the classification model. Other 
tools work with a smaller set of features (Cestarelli et al., 2016), or 
reduce the number of features applying regression algorithms 
(Danielsson et al., 2015). 
Datasets used in our experiments were extracted from TGCA and 
obtained using the HumanMethylation450 platform. This platform 
provides beta values for more than 485,000 CpG loci. Even if there are 
more than 28 million of CpG loci in the human genome, data from 
HumanMethylation450 cover 99% of RefSeq genes, so it is a good 
starting point to identify drivers for cancer.  
In our work, we have provided a methodology and a software tool to 
analyze HumanMethylation450 data and even bigger datasets. Then, 
genes extracted from the execution of BIGBIOCL (available at 
supplementary data S1) can be used by biologists to determine their 
relevance in a given type of cancer. If we consider that there are around 
25 thousand of genes in human DNA, limiting their number allows 
focusing the attention of the researcher. Analyzing results of experiments 
on BRCA data, we can find some genes that are well known in literature 
for their role in breast cancer. For example, mutations of the tumor 
suppressor gene TP53 and of PIK3CA have been often associated with 
BRCA (Kim et al., 2017). In addition, both inherited and de novo 
mutations of BRCA1 and BRCA2 – which mainly cause inactivity of 
such genes - have been associated to patients with breast cancer (King  et 
al., 2013; Antonucci et al., 2017). A recent study (Tsai  et al. 2017) 
argues that up-regulation of the BDNF signaling pathway can be 
associated to triple negative breast cancer cells (i.e. cells that test 
negative for HER2, estrogen receptors, and progesterone receptors). We 
have obtained BDNF as result of several experiments (IDs 12, 15, 16, 
and 17). Furthermore, other genes that are considered high-confidence 
oncogenic candidates (Zheng et al., 2016) have been extracted with 
BIGBIOCL, as ALDH3A1, CLDN15, SFN, and ENDOD1. 
5 Conclusion 
In conclusion, BIGBIOCL can efficiently manage large datasets, 
iteratively building equivalent classification models, extracting features 
(genes in our experiments where features are CpG loci, but the algorithm 
can potentially be used with other data), and scaling up with the size of 
the input dataset. Then, results need to be further validated. The 
algorithm can be improved. It currently builds the classification model 
on 70% of input data, using 30% of data as test data (the F-measure on 
test data is used as stopping condition of the iterations). This choice was 
important during the development and the test of BIGBIOCL. In order to 
get more precise results and to avoid to loose information, the algorithm 
could build classification models on 100% of the input data. In addition, 
as already said, BIGBIOCL can be applied to other type of data, 
including other NGS experiments and even bigger datasets. Lastly, 
BIGBIOCL can be used as a component of a pipeline to give sense to 
raw data, reducing the entropy and focusing the attention on a smaller set 
of dimensions. 
Acknowledgements 
We wish to thank the Cineca consortium for assigning us supercomputer resources 
[grant number HP10CTJZAM] to make possible the big data calculations and for 
providing the PICO infrastructure to carry on experiments with the Hadoop YARN 
cluster. This work was partially supported by the ERC Advanced Grant GeCo 
(datadriven Genomic Computing) [grant number 693174], the MoDiag Regione 
Lazio Project [grant number A0112-2016-13363], and the SysBioNet Italian 
Roadmap Research Infrastructures. Additionally, we wish to thank Paola Bertolazzi 
for supporting this work. Finally, we wish to thank Giulia Fiscon and Federica 
Conte for the patience demonstrated during the local experimentation phase. 
Conflict of Interest: none declared. 
References 
Akalin,A. et al. (2012) methylKit: a comprehensive R package for the analysis of 
genome-wide DNA methylation profiles. Genome Biology, 13:R87 
Antonucci,I. et al. (2017) A new case of "de novo" BRCA1 mutation in a patient 
with early-onset breast cancer. Clin Case Rep, 5(3), 238-240 
Bartlett, T.E., et al. (2014) A DNA methylation network interaction measure, and 
detection of network oncomarkers. PloS one 9.1, e84573. 
Baylin, S.B., et al. (2001) Aberrant patterns of DNA methylation, chromatin 
formation and gene expression in cancer. Human molecular genetics 10.7, 687-
692. 
Baylin, S.B. (2005) DNA methylation and gene silencing in cancer. Nature 
Reviews. Clin Oncol, 2(S1), S4. 
Bird, A. (2002) DNA methylation patterns and epigenetic memory. Gene dev. 
16(1), 6-21. 
Breiman, L (2001) Random Forests. Machine Learning 45(1), 5-32 
Cestarelli, V. et al. (2016) CAMUR: Knowledge extraction from RNA-seq cancer 
data through equivalent classification rules. Bioinformatics, 32(5), 697-704 
Cohen, W.W. (1995) Fast effective rule induction. Proceedings of the twelfth 
international conference of machine learning, 115-123. 
Danielsson, A. et al. (2015) MethPed: a DNA methylation classifier tool for the 
identification of pediatric brain tumor subtypes. Clinical Epigenetics, 7:62 
 De Carvalho, D.D. et al. (2012) DNA methylation screening identifies driver 
epigenetic events of cancer cell survival. Cancer Cell, 21, 655–67. 
Du, P. et al. (2010) Comparison of Beta-value and M-value methods for 
quantifying methylation levels by microarray analysis. BMC Bioinformatics, 
11, 587 
Dedeurwaerder, S. et al. (2014) A comprehensive overview of Infinium 
HumanMethylation450 data processing. Brief Bioinform, 15(6), 929–941 
Feinberg, AP. et al. (2006) The epigenetic progenitor origin of human cancer. Nat 
Rev Genet, 7(1), 21-33 
Figueroa, AP. et al. (2008) An Integrative Genomic and Epigenomic Approach for 
the Study of Transcriptional Regulation. PLOS ONE, 3(3): e1882 
Greene, C.S. et al. (2014) Big Data Bioinformatics. J. Cell. Physiol, 229, 1896–
1900 
Hall, M et al. (2009). The WEKA Data Mining Software: An Update. SIGKDD 
Explorations, 11(1). 
Hayden, E.C. (2014) The $1,000 genome. Nature, 507.7492, 294. 
Kim, J.Y. et al. (2017) Clinical implications of genomic profiles in metastatic 
breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated 
genes. Oncotarget, 8(17), 27997-28007 
King, M.C. et al. (2013) Breast and ovarian cancer risks due to inherited mutations 
in BRCA1 and BRCA2. Science, 302(5645), 643-6 
Kulis, M. et al. (2010) DNA methylation and cancer. Advances in genetics, 70, 27-
56. 
McKinsey, Global Institute (2012) Big Data: The next frontier for innovation, 
competition, and productivity. Report. 
Meng, X. et al. (2016) Mllib: Machine learning in apache spark. Journal of 
Machine Learning Research, 17(34), 1-7. 
Pidsley, R., et al. (2013) A data-driven approach to preprocessing Illumina 450K 
methylation array data. BMC genomics, 14(1), 293. 
Quinlan, R. (1993) C4.5: Programs for Machine Learning. Morgan Kaufmann  
Publishers. San Mateo CA: Morgan Kaufmann. 
Sandoval, J., et. al. (2011) C4.5: Validation of a DNA methylation microarray for 
450,000 CpG sites in the human genome. Epigenetics, 6(6), 692-702. 
Shendure, J. et. al (2008) Next-generation DNA sequencing. Nature biotechnology, 
26.10, 1135-1145. 
Stevens, M. et al. (2013) Estimating absolute methylation levels at single-CpG 
resolution from methylation enrichment and restriction enzyme sequencing 
methods. Genome Res, 23(9), 1541–1553 
Svetnik, V. et al. (2003) Random Forest: a classification and regression tool for 
compound classification and QSAR modeling. J Chem Inf Comp Sci, 43(6), 
1947-1958 
Tan, P. et al. (2005) Introduction to Data Mining. Addison Wesley, Oxford 
University Press, Oxford, UK 
Tomczak, K. et al. (2015) The Cancer Genome Atlas (TCGA) an immeasurable 
source of knowledge. Contemporary Oncology, 19(1A), A68-A77.  
Tsai, Y.F. et al. (2017) Brain-derived neurotrophic factor (BDNF) -TrKB signaling 
modulates cancer-endothelial cells interaction and affects the outcomes of triple 
negative breast cancer. PLoS One, 12(6), e0178173.  
Vavilapalli, V. K et al. (2013) Apache hadoop yarn: Yet another resource 
negotiator. In Proceedings of the 4th annual Symposium on Cloud Computing, 
ACM, 1-5.  
Weinstein, J.N. et al. (2013) The cancer genome atlas pan-cancer analysis project. 
Nat. Genet, 45, 1113–1120 
Weitschek, E. et al. (2014) Next generation sequencing reads comparison with an 
alignment-free distance. BMC Research Notes 7.1, 869. 
Weitschek, E. et al. (2014) Supervised DNA barcodes species classification: 
analysis, comparisons and results. BioData Min., 7, 4 
Weitschek, E. et al. (2016) Genomic Data Integration: A Case Study on Next 
Generation Sequencing of Cancer. 27th International Workshop on Database 
and Expert Systems Application, IEEE Computer Society, 49-53 
Zhao, Q. et al. (2015) Combining multidimensional genomic measurements for 
predicting cancer prognosis: observations from TCGA. Brief Bioinform, 16(2), 
291-303 
Zheng, Y. et al. (2016) Genome-wide DNA methylation analysis identifies 
candidate epigenetic markers and drivers of hepatocellular carcinoma. Brief 
Bioinform, bbw094 
Zhuang, J. et al. (2002) A comparison of feature selection and classification 
methods in DNA methylation studies using the Illumina Infinium platform. 
BMC Bioinformatics, 13:59 
